Industry / Pharmaceuticals: Other
Latest filings
F-6EF
ESALF
Eisai
6 Mar 23
Automatic registration for ADRs (foreign)
12:22pm
DFAN14A
INDV
Indivior
16 Feb 23
Additional proxy materials by non-management
5:13pm
F-6EF
ESALF
Eisai
9 Feb 23
Automatic registration for ADRs (foreign)
1:14pm
DFAN14A
INDV
Indivior
6 Feb 23
Additional proxy materials by non-management
12:14pm
CT ORDER
TTPH
Tetraphase Pharmaceuticals
1 Feb 23
Confidential treatment order
6:08am
F-6
ESALF
Eisai
20 Jan 23
Registration for ADRs (foreign)
3:22pm
F-6EF
ESALF
Eisai
9 Jan 23
Automatic registration for ADRs (foreign)
9:45am
DFAN14A
INDV
Indivior
20 Dec 22
Additional proxy materials by non-management
2:41pm
DFAN14A
INDV
Indivior
7 Dec 22
Additional proxy materials by non-management
10:27am
RW
Mallinckrodt
6 Dec 22
Registration withdrawal request
5:15pm
Upcoming Earnings Releases
News
Pfizer, Astellas Tout Positive Xtandi Data To Potentially Expand Label For The Prostate Cancer Drug
ALPMF
PFE
17 Mar 23
Alzheimer's Association Launches Grassroots Level Lobbying For Medicare Coverage Of Alzheimer's Treatments
BIIB
ESALF
LLY
16 Mar 23
Analyst Says Biogen-Eisai's Alzheimer's Treatment Leqembi Coverage Enables Access To Over $2.5B Market Opportunity
BIIB
ESALF
14 Mar 23
Eisai-Biogen Seek Complete FDA Approval For Its Second Alzheimer's Treatment
BIIB
ESALF
6 Mar 23
FDA Accepted Eisai-Biogen's Supplemental Biologics License Application For Leqembi (Lecanemab-IRMB) 100 mg/ml Injection For Intravenous Use, Supporting The Conversion Of The Accelerated Approval Of Leqembi To A Traditional Approval
BIIB
ESALF
6 Mar 23
Analyst Says Selecta Biosciences' Gout Candidate Can Potentially Raise The Bar On Several Fronts
ALPMF
HZNP
SELB
31 Jan 23
Sandoz Acquires Antifungal Agent From Astellas, Reinforcing Hospital Offering
ALPMF
GSK
NVS
24 Jan 23
Transcripts
ALPMF
Earnings call transcript
2022 Q3
31 Oct 22
SGIOF
Earnings call transcript
2022 Q1
2 Aug 22
EMHTF
Earnings call transcript
2021 Q2
31 Aug 21
EMHTF
Earnings call transcript
2020 Q4
3 May 21
FOMX
Earnings call transcript
2020 Q3
7 Nov 20
MYOK
Earnings call transcript
2020 Q2
5 Aug 20
MYOK
Earnings call transcript
2019 Q4
27 Feb 20
MYOK
Earnings call transcript
2019 Q2
7 Aug 19
MYOK
Earnings call transcript
2019 Q1
9 May 19
MYOK
Earnings call transcript
2018 Q4
4 Mar 19
Patents
Utility
Medicament for Preventing And/or Treating Dry Eye
SNPHY
23 Mar 23
Utility
Compositions and methods for treating cancer
21 Mar 23
Utility
Compositions and methods for treating cancer
7 Mar 23
Utility
Compositions and methods for treating cancer
28 Feb 23
Utility
Aqueous Suspension Composition Containing Sirolimus or Salt Thereof
SNPHY
23 Feb 23
Utility
Crystalline forms of eravacycline
TTPH
14 Feb 23
Utility
Ursodeoxycholic Acid-containing Agent for Treating or Preventing Presbyopia
SNPHY
9 Feb 23
Utility
HMGN partial peptide and cancer therapy using the same
OPHLY
7 Feb 23
Utility
Dihydroindolizinone derivative
OPHLY
31 Jan 23
Utility
Compositions and methods for treating cancer
24 Jan 23